QUANTUMONLINE.COM SECURITY DESCRIPTION:  Citigroup Funding Inc., 10% ELKS (Equity LinKed Securities) based on the common stock of Merck & Co. (NYSE: MRK), due 4/29/2009, and issued at $10 per ELKS. The ELKS pay a total of $1.0361 in cash composed of $0.3423 in interest and $0.6938 in option premium, which is payable on 10/29/2008 and 4/29/2009 to holders of record at the close of business on the third business day prior to the payment date. At maturity the holder will receive either 0.24307 common shares of Merck if the price of Merck's shares at any time during the term of the ELKS is less than or equal to $30.86 (75% of the initial share price of $41.14 on 4/11/2008) or $10 in cash. The ELKS are not principal protected and at maturity the holder could receive common shares whose value is less, and possibly significantly less, than the original investment in the ELKS. See page PS-2 of the IPO prospectus for further information on the maturity payment and page PS-10 for hypothetical examples of the maturity payment. For further information on the ELKS, see the IPO prospectus by clicking on the ‘Link to IPO Prospectus’ provided below. The ELKS are senior unsecured debt securities issued by Citigroup Funding Inc., guaranteed by Citigroup Inc. and will rank equally with all of their other unsecured and unsubordinated debt. Citigroup Funding Inc. is a wholly-owned subsidiary of Citigroup Inc. (NYSE: C) whose business activities consist of providing funds to Citigroup Inc. and its subsidiaries for general corporate purposes.

Company's Online Information Links

HOME PAGE:     http://www.citigroup.com/ (This parent company URL is for reference only and does not have specific information on the security.)

Company's Online SEC EDGAR Filings

Company's SEC EDGAR Filings

Go to SEC Filings

Address and Phone Numbers

Address:   399 Park Avenue, New York, NY 10043
Main Phone Number	212-559-1000
Fax Number	Not Available